DUBLIN--(BUSINESS WIRE)--The "Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease ...
CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The cardiac marker testing industry is poised for significant advancements in the near future, driven by breakthroughs in diagnostic technologies and an ...
The findings are published in the Journal of Cardiac Failure. "Several markers have been examined heart failure and its adverse outcomes, but few have ever shown to be additive to BNP, or sometimes ...
To investigate whether creatine kinase-MB (CK-MB) and cardiac troponin I (cTnI) can be used to predict neurodevelopmental outcome at 18 months in infants with perinatal asphyxia (PA). The diagnostic ...
HFpEF, a significant and common health burden that is increasing in prevalence, is associated with an elevated risk of SCD. In a retrospective analysis of data from the TOPCAT study, researchers ...
Study reveals no significant differences by race/ethnicity or sex. (HealthDay News) — Slightly higher levels of cardiac biomarkers may predict an increased risk for incident cancer, according to a ...
CCN5 reduced cardiac cellular senescence in preclinical models of cardiovascular disease. Learn how this could shape ...
Beyond total cholesterol, these few other indicators may help provide more profound information about the chances of a person having heart disease.
When examining data from 10,889 participants, researchers found a consistent association for markers of systolic dysfunction with smaller total brain volume. HealthDay News — Subclinical cardiac ...
Researchers have identified a very early marker of cardiac damage in patients undergoing therapy with anthracyclines, a family of drugs commonly used to treat cancer. This finding will enable the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results